PF-5212371

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NamePF-5212371
Drug Alias NameAGG-523PF-05212371WAY-266523PF-5212371
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAggrecan core protein inhibitors
TargetsAggrecan core protein
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer IncWyeth Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWyeth Llc
Active IndicationsN/A
Inactive IndicationsOsteoarthritis

Other Information

ATC CodeN/A
Related LinksN/A